Articles On Avita Medical (ASX:AVH)

ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7%  Neuren soars on sale of priority review voucher and $50 million share buyback Neurizon releases positive preclinical results on lead drug candidate...

Emyria says the Trump administration’s expected liberalisation of psychedelic therapies was the likely reason for yesterday’s 42% share spurt  Avita Medical brings it home with an Aussie distribution deal  EBR System expects US approval fo...

If you are a fan of small cap ASX shares, then you will be pleased to know that analysts have recently named a number as buys. Here's what you need to know about these shares from the small side of the market: AVITA Medical Inc (ASX: AVH)...

Several ASX healthcare companies have upcoming catalysts, which can be a focal point for healthcare investors Dimerix forecasts the second interim analysis of its ACTION 3 global phase III trial of DMX-200 to treat FSGS in around mid-CY25...

The ASX200 closed 0.84% at 8,295 points. The market remains buoyant in the wake of Trump’s election in the United States, and the expectation China will ramp up stimulus measures. IT finished the session the best performing sector, up...

AVITA Medical (Nasdaq: RCEL, ASX: AVH), a leader in regenerative medicine with its proprietary RECELL technology, reported a substantial increase in revenue for the third quarter ended 30 September 2024. The company recorded commercial reve...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

ASX health stocks fall 2.15% in past five days, while broader market down 1.42%  MedAdvisor drops 30% on latest quarterly result as MicroX and Mach 7 also fall Micro X reports a ‘ho-hum’ results, while AGMs so far remain rather uneventful ...

Investors that are looking for exposure to the small side of the market, might want to check out the small cap ASX shares listed below. That's because they were recently named as buys by brokers and tipped to rise strongly from current leve...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Many analysts believe that interest rate cuts will put a rocket under small cap ASX shares, which have been underperforming during the rate hike cycle. And while Australian interest rates may not be heading lower until next year, it could p...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

The Dicker Data Ltd (ASX: DDR) share price is having a difficult finish to the week. In morning trade, the wholesale computer hardware and software distributor's shares are down 9.5% to $9.16. Investors have been hitting the sell button in...

ASX health stocks rise 0.8% past five days as broader market lifts 3.7%  Morgans says ProMedicus ‘produced yet another record result’ with net profit of $82.8m in FY24  CSL falls on FY24 results but Morgans still bullish on ASX’s largest h...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7832.00 + 28.00 0.36% S&P ASX 200 7850.70 +...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7829.00 + 59.00 0.76% S&P ASX 200 7826.80 +...

It's been a decent, if unspectacular, day for the S&P/ASX 200 Index (ASX: XJO) so far this Tuesday. At the time of writing, the ASX 200 has gained a tentative 0.18% and is up to just under 7,830 points. But the performance of the JB Hi-...

The CAR Group Limited (ASX: CAR) share price had a strong start to the week on Monday. The ASX 100 share ended the session 4.5% higher at $35.14. Investors were buying the auto listings company's shares following the release of its full y...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7762.00 + 3.00 0.04% S&P ASX 200 7813.70 + 3...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a positive fashion. The benchmark index rose 0.45% to 7,813.7 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected...

This Monday, the S&P/ASX 200 Index (ASX: XJO) and, by extension, many ASX shares had a stellar start to the trading week. After soaring on Friday, the ASX 200 kept up the momentu...

It's been a great start to the trading week this Monday for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares by extension. At the time of writing, the ASX 200 has added a healthy 0.42%, pulling the index back up over 7,800 points. B...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Monday. At the time of writing, the benchmark index is up 0.5% to 7,818.1 points. Four ASX shares that are rising more than most today are listed below. Here's why they are pushing hi...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AZJ)) - Auriz...

Dicker Data Ltd (ASX: DDR) has kicked off the week with a positive start, announcing an 11 cents per share dividend before the market opened today. The announcement has driven DDR shares up 4% at the time of writing, with the stock now...

The CAR Group Ltd (ASX: CAR) share price is leaping higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) auto listings company closed on Friday trading for $33.64. In morning trade on Monday, shares are changing hands for $34.92...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ending 30 June 2024. For context,...

Neuren shows promise in Angelman drug but shares down 7pc Avita aims for profitability by Q3 FY25 IDT lands $2.5-$4m mRNA contract with Sanofi   Neuren’s Angelman drug shows promise Market darling Neuren Pharmaceuticals (ASX:NEU) has just...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Indications are the ASX is poised for a strong session today. World Overnight SP...

Recent market trends have shown a notable downturn, marking the most significant decline since the disruptions experienced in 2022. While such volatility can create unease, it also presents opportunities to acquire high-quality stocks at at...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

ASX health stocks rise 0.9% in past five days as broader markets lift 1.2%, despite Friday selloff ImpediMed’s latest quarterly result shows sales momentum building for Sozo device  Cold-cathode X-ray machine developer MicroX makes progres...

The ASX200 hit a fresh record high and closed up around 0.3% at 8,115 points, as the 2024 Wall Street rally continues to buoy Australian sentiment. Almost all sectors were up, led by Real Estate up 1.7%, followed closely by Information T...

ASX healthcare shares have outperformed in the past 12 months. The broad index, represented by the S&P/ASX 200 Index (ASX: XJO), is up 10.5% in that time. Meanwhile, the S&P/ASX 200 Health Care Index (ASX: XHJ), a proxy for the l...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Avita (ASX:AVH) has announced its development of a ‘dermal matrix’ – in other words, a kind of next-gen gauze made of a material closer to skin than cotton. The product’s development is being collaborated on with another entity called Re...

The ASX s expected to rise after the Fed suggested a possible rate cut in September Nasdaq soared by 2.64pc, with Nvidia surging by 12pc Gold and oil prices also surged due to geopolitical tensions   The ASX200 index is expected to climb...

The ASX is set to rise a fifth of a percent on Thursday according to futures around 8.30am Sydney time. Overnight, the US Federal Reserve made its latest interest rate decision; keeping rates on hold but signalling a September cut is sti...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Australian investors have shown an interest in ASX small-cap shares in recent weeks amid a sharp correction in the broader markets. As we entered the new financial year, the S&P/ASX Small Ordinaries Index (ASX: XSO) rallied 4.6% to...

Small cap ASX shares can be great additions to a balanced investment portfolio. This is because they tend to offer stronger than average returns. However, as they are higher risk options, they are generally unsuitable for investors with a l...

  Special Report: Dropping milestone numbers this week is the Perth-based regenerative medtech Orthocell, for which record quarterly and full year revenue has been driven by a huge uptick in demand across the company’s flagship healing solu...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

For biotech investors, the news of an approval by the US FDA is a genuinely exciting milestone. The FDA is the ultimate gatekeeper for the US pharmaceutical market, which is by far the world’s largest. Approval from the FDA not only validat...

If you have a high tolerance for risk, then it could be worth adding some exposure to small caps to your investment portfolio. Especially when analysts are tipping the three in this article to deliver outsized returns for investors over the...

For investors that have a high risk tolerance, it could be worth considering some small cap ASX shares for your portfolio. That's because the returns on offer at the small side of the market can be material. But which small caps could offe...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced that the US FDA has approved its premarket approval supplement for the RECELL GO System.

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Are you looking for big returns for your investment portfolio? If you are, then take a look at the three ASX shares listed below that have been tipped to rise materially by analysts. Here's what you need to know about them: AVITA Medical I...